Era-Net (MOH): “Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy” (TRANSCAN-3)- Pre Proposals

The Second Joint Transnational Call for Proposals 2022 (JTC 2022): Novel Translational Approaches to Tackle the Challenges of Hard-to-Treat Cancers From Early Diagnosis to Therapy invites proposals centred on one or more of the hard-to-treat-cancers (HTTC) subtypes characterised by very poor prognosis (five year survival rate<25%) and for which survival has not improved significantly over the last decades, namely glioblastoma, oesophageal, pancreatic, gallbladder, liver, and lung/pleural cancers.

Proposals will have to cover at least one of three specific aims

• Aim 1: Identification/validation of novel early diagnostic approaches
• Aim 2: Identification/validation of novel therapeutic approaches
• Aim 3: Development of novel drug delivery strategies

Only transnational projects will be funded. Each research consortium must involve a minimum of three and a maximum of six eligible partners from at least three different countries participating in the call. In addition, a research consortium must not involve more than two research groups from one country.

Funding: Up to 140 000 € (in NIS) per project.
An additional 20 000 Euros (in NIS) will be granted if the Israeli researcher is the coordinator
https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl